MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CUE made $2,149,000 in revenue. -$7,447,000 in net income. Net profit margin of -346.53%.

Income Overview

Revenue
$2,149,000
Net Income
-$7,447,000
Net Profit Margin
-346.53%
EPS
-$0.07
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenue
2,149,000 2,954,000 421,000 1,983,666.667
General and administrative
4,939,000 3,679,000 4,173,000 3,906,000
Research and development
4,754,000 7,910,000 8,547,000 8,971,333.333
(gain) loss on fixed asset disposal
----1,333.333
Loss (gain) on fixed asset disposal
-51,000 ---
Total operating expenses
9,744,000 11,589,000 12,720,000 12,878,666.667
Loss from operations
-7,595,000 -8,635,000 -12,299,000 -10,895,000
Interest income
222,000 198,000 170,000 426,333.333
Interest expense
-75,000 -45,000 -128,000 -202,666.667
Total other income, net
147,000 153,000 42,000 223,666.667
Net loss
-7,448,000 -8,482,000 -12,257,000 -10,671,333.333
Unrealized gain from available-for-sale securities
1,000 ---
Comprehensive loss
-7,447,000 -8,482,000 -12,257,000 -10,671,333.333
Net loss per common share, basic
-0.07 -0.09 -0.17 -0.183
Net loss per common share, diluted
-0.07 -0.09 -0.17 -0.183
Weighted average common shares outstanding, basic
100,869,349 95,459,401 74,254,700 1,699,549
Weighted average common shares outstanding, diluted
100,869,349 95,459,401 74,254,700 1,699,549
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$7,447,000 Unrealized gain fromavailable-for-sale securities$1,000 Interest income$222,000 Net loss-$7,448,000 Total other income,net$147,000 Interest expense-$75,000 Loss from operations-$7,595,000 Collaboration revenue$2,149,000 Total operatingexpenses$9,744,000 Loss (gain) on fixedasset disposal-$51,000 Research and development$4,754,000 General andadministrative$4,939,000

Cue Biopharma, Inc. (CUE)

Cue Biopharma, Inc. (CUE)